Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation

Patent metadata

Field	Value
Publication number	US-10070643-B2
Application number	US-201414780832-A
Country	US
Kind code	B2
Filing date	Mar 28, 2014
Priority date	Mar 28, 2013
Publication date	Sep 11, 2018
Grant date	Sep 11, 2018

Abstract

It has been discovered that isolated organs and tissues perfused/reperfused in perfusion buffer to which omega-3 glyceride oil had been added retain higher levels of function than if perfused/reperfused without the omega-3 glycerides. Isolated hearts reperfused ex vivo after induced ischemia in n-3 triglyceride perfusion emulsion maintained a normal heart rate and normal LVDP and showed a dramatically reduced frequency of arrhythmias compared to control hearts. Further, test hearts reperfused with n-3 oil triglyceride emulsion showed a decrease in creatine kinase and upregulation of certain beneficial proteins including the anti-apoptotic gene marker Bcl-2.

First claim

What is claimed is:

1. A method comprising
(a) providing an oil in water emulsion comprising
(i) a perfusion buffer suitable for organ or tissue preservation and transplantation,
(ii) 0.5% to 7% of an omega-3 oil by weight in grams per 100 ml of perfusion buffer, wherein the omega-3 oil comprises
1) from about 10% to about 99% and omega-3 diglyceride, omega-3 triglyceride or combinations thereof by weight per total weight of the omega-3 oil, and at least about 20% to about 99% of the total acyl groups of the diglycerides and triglycerides comprise EPA, DHA, or combinations thereof, and
2) less than 10% omega-6 fatty acids by weight per total weight of the omega-3 oil,

(iii) less than 10% omega-6 oil by weight in grams per 100 ml of perfusion buffer, and
(iv) wherein the mean diameter of lipid droplets in the emulsion is from about 100 nm to less than about 5 microns, and

(b) either perfusing or reperfusing an isolated organ or tissue ex vivo with the emulsion at a temperature of −5° C. to 37° C. for a duration of 1 hour to 72 hours to preserve the organ or tissue until it is transplanted into a recipient or is otherwise used.

2. The method of claim 1 , wherein the organ and tissue is selected from the group comprising liver, lung, pancreas, skin, heart, heart valve, bone, bone marrow, blood vessels, lymph nodes, intestine, teeth, gingiva, small bowel, colon, appendages, scalp, epithelium or blood for transfusion.

3. The method of claim 1 , wherein the organ is a heart, liver, kidney, pancreas, or lung.

4. A method for preserving or preparing an isolated organ or tissue for transplant, comprising either perfusing or reperfusing the organ or tissue ex vivo at a temperature of −5° C. to 37° C. for a duration of 1 hour to 72 hours until it is transplanted into a recipient or is otherwise used, with an omega 3 emulsion comprising
(i) 0.5% to 7% of an omega-3 oil by weight in grams per 100 ml of perfusion buffer, wherein the omega-3 oil comprises
1. from about 10% to about 99% and omega-3 diglyceride, omega-3 triglyceride or combinations thereof by weight per total weight of the omega-3 oil, and at least about 20% to about 99% of the total acyl groups of the diglycerides and triglycerides comprise EPA, DHA, or combinations thereof, and
2. less than 10% omega-6 fatty acids by weight per total weight of the omega-3 oil,

(ii) less than 10% omega-6 oil by weight in grams per 100 ml of perfusion buffer, and
(iii) wherein the mean diameter of lipid droplets in the emulsion is from about 100 nm to less than about 5 microns.

5. The method of claim 1 , wherein
the duration of time is about 6 hours.

6. The method of claim 1 , wherein the temperature is from −5° C. to 10° C.

7. The method of claim 1 , wherein the temperature is 0° C. to 4° C.

8. The method of claim 1 , wherein the temperature is 4° C. to 37° C.

Assignees

• Univ Columbia

Inventors

• Deckelbaum Richard J
• Ramasamy Ravichandran

Classifications

• A61K31/202

  having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title

• A01N1/0226 Primary

  Human Necessities · mapped topic

• A01N1/126 Primary

  Physiologically active agents, e.g. antioxidants or nutrients · CPC title